Reinsurance

Board Questions to Ask About Trapped Capital Across Legal Entities

Posted by Hitul Mistry / 03 Aug 26

Board Questions to Ask About Trapped Capital Across Legal Entities

Boards of reinsurance groups must move beyond Group SCR coverage ratios and ask specific questions about where capital sits, whether it can move, and what trapped surplus is costing the group. The Group SCR ratio may be 175% while one entity operates at 125% and another sits at 250%, with the surplus in the overcapitalised entity inaccessible to the constrained one. A board that governs only the group-level ratio is governing capital adequacy at a level of aggregation that conceals the legal entity reality. The questions the board asks about trapped capital define the quality of its capital governance. A board that does not ask these questions cannot fulfil its fiduciary duty to oversee the group's capital position.

Why do board questions about trapped capital matter more now?

Regulatory expectations for board oversight of capital fungibility have intensified. EIOPA's supervisory statements require boards to understand the group's capital position at both group and solo levels. The PRA's senior insurance managers regime holds directors personally accountable for decisions made on the basis of capital information. A director who approves the ORSA without questioning whether it assumes capital fungibility that does not exist may face personal regulatory exposure if that assumption proves material. The board's questions are not merely good governance practice; they are a regulatory necessity. For the regulatory context, see Solvency Relief and Reinsurance Capital: Strategic Dimensions.

Rating agencies have made capital fungibility a specific focus of their ERM assessments. Boards that cannot demonstrate systematic oversight of trapped capital will see weaker ERM scores, which flow into rating assessments. The board's questions about trapped capital are thus not only a governance activity but a rating agency management activity. Visit Insurnest to build the board dashboards that enable these questions. For the governance framework, see Enterprise Risk and Strategic Reinsurance and Credit Reinsurance Through the Cycle.

What goes wrong when the board does not ask trapped capital questions?

When the board accepts aggregated capital reporting without probing the legal entity picture, each one below converts a governance gap into a capital management failure.

1. How does the absence of board questions allow trapped capital to accumulate without governance attention?

Without the board asking for a legal entity capital map, management has no incentive to produce one. The board receives the Group SCR coverage ratio, notes that it is within appetite, and moves to the next agenda item. The trapped capital accumulating in legacy entities never appears on the board's radar. Management is not concealing the problem; the board is simply not asking the questions that would reveal it. The board's silence on trapped capital is interpreted by management as acceptance of the status quo.

2. How does the absence of board questions about the ORSA allow fungibility assumptions to go untested?

The board approves the ORSA annually, but if it does not ask whether the projections assume full capital fungibility, it may be approving a capital adequacy assessment that overstates resilience. The ORSA may project that capital will be available to absorb losses wherever they occur, when in practice trapped capital in specific entities cannot be mobilised. The board's approval of the ORSA without questioning fungibility assumptions is a governance failure that regulators are increasingly challenging.

3. How does the absence of board questions about capital return decisions create structural inefficiency?

When the board approves dividends or buybacks without asking whether trapped capital constrains upstreaming, it may be approving capital returns that require the parent to borrow while surplus sits locked in subsidiaries. This is not deliberate capital structure management; it is an unintended consequence of the board not understanding where capital sits. The board that asks the trapped capital question before approving capital returns ensures that returns are funded from genuinely available surplus, not from debt incurred because surplus is inaccessible.

4. How does the absence of board questions about intragroup reinsurance create ungoverned risk transfer?

Intragroup reinsurance structures that release trapped capital involve genuine risk transfer between regulated entities. The board that does not ask about the governance, pricing, and regulatory approval of these structures is exposed to the risk that they are challenged by regulators, creating capital adequacy uncertainty. The board's questions about intragroup reinsurance demonstrate the governance oversight that regulators expect.

5. How does the absence of board questions weaken the board's standing with regulators and rating agencies?

When a regulator conducts a supervisory review and asks the board about capital fungibility, the board's inability to answer detailed questions about trapped capital reveals a governance gap. The regulator may conclude that the board is not effectively overseeing capital management. Rating agency analysts reach similar conclusions. The board's credibility with external stakeholders is diminished, and that diminution has financial consequences through increased supervisory intensity and rating pressure.

The board that does not ask about trapped capital does not govern it. Start asking.

Talk to Our Specialists

Visit Insurnest to develop the board briefing pack that frames the trapped capital questions.

What questions should the board ask about trapped capital?

The board should ask five categories of questions: visibility, risk appetite, financial impact, management action, and external communication. Consider the Risk Committee of a Bermudian reinsurer that developed a trapped capital question framework after the committee chair realised that no board member could answer the question "where does our capital actually sit?" The committee developed a structured question set that it now uses at every quarterly meeting.

The question set transformed the board's capital governance. Within two quarters, management had produced the legal entity capital map the board requested, and the trapped capital of 11% of group equity was identified and addressed. The board's questions catalysed management action that reduced trapped surplus by 60% over eighteen months. That is what every board should be doing: asking the questions that convert capital governance from passive receipt of aggregated metrics to active oversight of capital location and fungibility.

  • "Produce a legal entity capital map showing solo capital, solo SCR, group allocation, and trapped surplus for every regulated entity." This is the foundational question. Without the map, the board cannot see the trapped capital position. Management should be asked to produce this map quarterly.
  • "What is the trapped capital tolerance embedded in our risk appetite, and are we operating within it?" If the risk appetite statement does not address capital fungibility, the board should direct management to add a trapped capital metric to the framework.
  • "What is the margin cost of our trapped capital in basis points of ROE, and what is the trend?" The board should receive a quantified margin cost quarterly. Management should explain the drivers of change and the actions taken to reduce the cost.
  • "Does our ORSA assume full capital fungibility? If so, what would the ORSA look like with entity-level constraints applied?" The board should require an ORSA sensitivity analysis showing the impact of trapped capital on projected solvency under stress. The board should not approve an ORSA that overstates fungibility.
  • "Are we returning capital to shareholders at the parent level while surplus is trapped in subsidiaries? If so, is this a deliberate capital structure decision?" The board should approve capital returns only after satisfying itself that the capital being returned is genuinely available, not funded by debt incurred because surplus is inaccessible.
  • "What intragroup reinsurance structures are in place to manage trapped capital, and what independent assurance do we have that they achieve genuine risk transfer?" The board should receive independent assurance from internal audit or external actuarial review, not solely from management's assessment.
  • "When did management last engage with our lead supervisor on capital fungibility, and what was the outcome?" The board should expect proactive regulatory engagement and should receive a summary of regulatory feedback on the group's capital fungibility framework.
  • "How does our trapped capital position and disclosure compare to our peer group?" The board should receive periodic benchmarking against peers. Material divergence should be explained by management.
  • "What is the annual trapped capital release plan, what are the targets, and what progress has been made this quarter?" The board should approve the annual plan and monitor quarterly progress against it. Variance from plan should be explained.
  • "How do we satisfy ourselves that management has identified all trapped capital and that the picture presented to us is complete?" The board should periodically commission independent review from internal audit or external advisors to validate the completeness and accuracy of management's trapped capital reporting.

How can boards build the capability to ask and govern trapped capital?

Building this capability requires defining the board's information requirements, embedding trapped capital in the risk appetite framework, integrating with ORSA oversight, establishing independent assurance, and sustaining the questioning discipline. Each addresses one of the governance failures above.

1. How should the board define its trapped capital information requirements?

The board should specify the trapped capital information it requires quarterly: a legal entity capital map, margin cost quantification, ORSA fungibility sensitivity, progress against the release plan, and regulatory engagement summary. The specification should be documented in the board information policy and communicated to the CFO and CRO. The Capital Relief Estimation AI Agent provides the analytics.

2. How should trapped capital be embedded in the risk appetite framework?

The board should approve a capital fungibility metric with defined tolerance, for example, trapped surplus not to exceed 5% of group shareholders' equity, and require quarterly reporting of actual against tolerance. Inclusion in the risk appetite framework ensures that trapped capital is governed with the same rigour as other material risks.

3. How should trapped capital oversight be integrated with ORSA governance?

The board should require that every ORSA submission includes a capital fungibility sensitivity analysis showing the impact of trapped capital on projected solvency. The board should not approve the ORSA until it has reviewed and discussed this analysis. The Reinsurance Risk Transfer Validator AI Agent supports the ORSA integration.

4. How should the board establish independent assurance on trapped capital?

The board should commission periodic independent review of trapped capital identification, measurement, and reporting from internal audit or external advisors. The review should validate that management's trapped capital picture is complete and that release mechanisms are operating as described.

5. How should the board sustain its trapped capital questioning discipline?

Trapped capital should be a standing quarterly agenda item for the Risk Committee. The committee should use the structured question set at each meeting and should report to the full board on the trapped capital position and management's performance against the release plan. Visit Insurnest for the board governance infrastructure.

6. How should the board communicate its trapped capital oversight to external stakeholders?

The board should ensure that the annual report and regulatory submissions include appropriate disclosure of the board's oversight of capital fungibility. Rating agency meetings should include discussion of the board's trapped capital governance, demonstrating board-level ownership. For the communication framework, see Credit Reinsurance Through the Cycle.

The board's questions are its primary governance tool. Use them.

Talk to Our Specialists

Visit Insurnest to equip your board with the trapped capital question framework.

What does board questioning deliver in practice?

Return to the Bermudian reinsurer's Risk Committee. Eighteen months after implementing the structured question set, the board now receives a quarterly trapped capital dashboard. The risk appetite framework includes a trapped capital tolerance. The ORSA includes a fungibility sensitivity analysis. Independent assurance on trapped capital has been provided by internal audit. Trapped surplus has declined by 60%. The board's capital governance has been acknowledged by rating agencies as a strength.

The broader reflection is that the board's primary governance tool is the questions it asks. A board that asks detailed, evidence-based questions about trapped capital will receive the information and management attention required to address it. A board that does not ask will not. The question framework described here provides the structure for effective board questioning, and boards that adopt it transform their trapped capital governance from passive to active. For more, see Enterprise Risk and Strategic Reinsurance.

Ask the questions. Govern the capital. Fulfil the fiduciary duty.

Talk to Our Specialists

Visit Insurnest to start your board's trapped capital governance journey.

Conclusion

The board's questions about trapped capital define the quality of its capital governance. A board that asks only about the Group SCR coverage ratio governs capital at a level of aggregation that conceals the legal entity reality. A board that asks the ten questions described here governs capital location, fungibility, and cost with the rigour that fiduciary duty requires.

The questions are not difficult to ask. They require no technical expertise beyond what directors already possess. What they require is the board's willingness to move beyond the aggregated metrics that management prefers to present and to probe the legal entity picture that reveals where capital actually sits. Boards that make this transition transform their capital governance and, in doing so, improve the capital efficiency, rating agency standing, and strategic flexibility of the groups they govern.

Frequently asked questions

What is the most important question a board should ask about trapped capital?

The board should ask management for a legal entity capital map showing solo available capital, solo SCR, group-diversified allocation, and trapped surplus for every regulated entity. Without this, the board cannot assess true capital resilience.

How does trapped capital relate to the board's risk appetite statement?

The risk appetite statement should include a capital fungibility metric setting tolerance for trapped surplus as a percentage of group equity. Without this, the board governs capital adequacy at a level that may not reflect actual resilience under stress.

What trapped capital information should the board receive quarterly?

A dashboard showing trapped surplus by entity as percentage of group equity, margin cost in basis points, external retrocession spend attributable to trapped capital, progress against the release plan, and forward projection under base and stress.

How should the board satisfy itself that intragroup reinsurance structures are robust?

The board should require independent assurance from internal audit, external auditor, or independent actuarial review that structures achieve genuine risk transfer, are priced at arm's length, and are disclosed to regulators.

What Risk Committee agenda items should address trapped capital?

Trapped capital should be a standing quarterly agenda item covering the dashboard, regulatory engagement, rating agency feedback, and progress against the release plan, with an annual deep-dive review of the fungibility policy.

How does trapped capital interact with the board's oversight of the ORSA?

The board should ask whether ORSA projections assume full capital fungibility or incorporate entity-level constraints. If ORSA assumes fungibility that does not exist, the board is approving an overestimated resilience assessment.

What questions should the board ask about trapped capital and dividend policy?

The board should ask whether trapped capital limits upstreaming to the parent and whether dividend commitments are sustainable given the trapped position. Borrowing to fund dividends while surplus is trapped requires deliberate board decision.

How can the board test whether management is giving a complete picture?

The board can commission an independent trapped capital review from internal audit or external advisors, compare the group's disclosure against peers, and ask the external auditor to comment on adequacy of identification and reporting.

About the author

Hitul Mistry is the Founder of Insurnest, an InsurTech company that engineers end-to-end technology exclusively for the insurance industry serving carriers, TPAs, MGAs, brokers, and reinsurers across India, the UAE, and the US. With more than a decade of insurance domain experience, he has built systems spanning underwriting automation, AI-powered underwriting intelligence, claims management, rating and quoting, broking and agency platforms, and reinsurance automation across Health/GMC, Group Life, Motor, P&C, and Reinsurance. Insurnest doesn't adapt generic software to insurance; it builds from the workflow up.

Connect with Hitul on LinkedIn.

Meet Our Innovators:

We aim to revolutionize how businesses operate through digital technology driving industry growth and positioning ourselves as global leaders.

circle basecircle base
Pioneering Digital Solutions in Insurance

Insurnest

Empowering insurers, re-insurers, and brokers to excel with innovative technology.

Insurnest specializes in digital solutions for the insurance sector, helping insurers, re-insurers, and brokers enhance operations and customer experiences with cutting-edge technology. Our deep industry expertise enables us to address unique challenges and drive competitiveness in a dynamic market.

Get in Touch with us

Ready to transform your business? Contact us now!